Abstract:Introduction: Gypenoside is a natural extract of Gynostemma pentaphyllum (Thunb.) Makino, a plant in the Cucurbitaceae family. It has been reported to have antitumor effects on the proliferation, migration and apoptosis of various types of cancer cells. However, the use of gypenoside in the treatment of gastric cancer has not been studied. In the present study, we explored the therapeutic effect of gypenoside on gastric cancer and the potential molecular mechanism. Methods and Results: Our results showed that gypenoside induced apoptosis in HGC-27 and SGC-7901 cells in a time-dependent and dose-dependent manner. Network pharmacology analyses predicted that gypenoside exerts its therapeutic effects through the PI3K/AKT/mTOR signaling pathway. Furthermore, molecular docking and western blot experiments confirmed that gypenoside induced the apoptosis of gastric cancer cells through the PI3K/AKT/mTOR signaling pathway. In addition, network pharmacological analysis revealed that the common targets of gypenoside in gastric cancer were enriched in the immune effector process, PD-L1 expression, the PD-1 checkpoint pathway, and the Jak-STAT signaling pathway. Furthermore, molecular docking and western blot assays demonstrated that gypenoside could bind to STAT3 and reduce its phosphorylation. Thus, the transcription of PD-L1 was inhibited in gastric cancer cells. Moreover, coculture experiments of gastric cancer cells with gypenoside and primary mouse CD8 + T cells showed that gastric cancer cells treated with gypenoside could enhance the antitumor ability of T cells. Animal experiments confirmed the antitumor effect of gypenoside, and the expression of PD-L1 was significantly downregulated in the gypenoside-treated group. Conclusion: Gypenoside induced the apoptosis of gastric cancer cells by inhibiting the PI3K/AKT/mTOR pathway and simultaneously inhibited the expression of PD-L1 in gastric cancer cells, thus enhancing the antitumor immunity of T cells. This study provides a theoretical basis for applying gypenoside as a new therapeutic agent to enhance the efficacy of immunotherapy in gastric cancer.

GYPENOSIEDS INDUCE APOPTOSIS IN HUMAN HEPATOMA CELLS

Apoptosis of Human Hepatoma Cells Induced by Gynostemma Pentaphyllum Makino

[Effects of Hepatocyte Growth Factor Gene Transfection on Adriamycin-Induced Apoptosis of Gastric Cancer Cells in Vitro].

Effect of Gp73 Silencing on Proliferation and Apoptosis in Hepatocellular Cancer

Guggulsterone Induces Apoptosis of Human Hepatocellular Carcinoma Cells Through Intrinsic Mitochondrial Pathway

Gambogic Acid Induced Apoptosis in Human Hepatoma SMMC-7721 Cells with P53 and Bax Up-Regulated

Pomegranate Peel Extract Polyphenols Induced Apoptosis in Human Hepatoma Cells by Mitochondrial Pathway

Activation of Peroxisome Proliferator-Activated Receptor Gamma Induces the Apoptosis in Human Colon Cancer Cells

Hydroxysafflor-Yellow A Induces Human Gastric Carcinoma BGC-823 Cell Apoptosis by Activating Peroxisome Proliferator-Activated Receptor Gamma (Pparγ)

Gypenosides Induced Apoptosis in Human Colon Cancer Cells Through the Mitochondria-Dependent Pathways and Activation of Caspase-3.

Effects of {2-[(3-carboxy-1-oxoprogy1)amino]-2-deoxy- D -glucose} on human hepatocellular carcinoma cell line

Apigenin Induces Apoptosis in Human Lung Cancer H460 Cells Through Caspase- and Mitochondria-Dependent Pathways

[Epigallocatechin Gallate Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells Via TGF/Smad Signaling Pathway].

Effects of {2-[（3-carboxy-l-oxoprogyl）amino]-2-deoxy-d-glucose} on Human Hepatocellular Carcinoma Cell Line

Effects of HMGBI Inhibition on the Apoptosis of Human Pancreatic Cancer Cells

Panax Japlcus Var Induced Apoptosis of Human Hepatocarcinoma Cells in Vitro

[Peroxisome Proliferator Activated Receptor Gamma Coactivator-1 Induces Apoptosis in Human Epithelial Ovarian Cancer Cells].

Effects of Ginsenoside Rg3 on growth and apoptosis of hepatic carcinoma cells lines in vitro

Geniposide reduced oxidative stress-induced apoptosis in HK-2 cell through PI3K/AKT3/FOXO1 by m6A modification

Gypenoside induces apoptosis by inhibiting the PI3K/AKT/mTOR pathway and enhances T-cell antitumor immunity by inhibiting PD-L1 in gastric cancer

20(S)-Protopanaxadiol induces apoptosis in human hepatoblastoma HepG2 cells by downregulating the protein kinase B signaling pathway.